Identifying and Solving Top Challenges to Oncology Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of test results with clinical outcomes, and the development of companion diagnostics for certain immunotherapies.

Related Videos

September 20, 2013

Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products

October 7, 2016

Tailoring Treatment Regimens for Patients with HR+/HER2-Negative Metastatic Breast Cancer

Dr Sunil Verma identifies how he makes treatment decisions for his patients, noting that he tends to use endocrine treatments instead of chemotherapy.